KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Rigel Pharmaceuticals (RIGL) Long-Term Debt Issuances (2022 - 2023)

Historic Long-Term Debt Issuances for Rigel Pharmaceuticals (RIGL) over the last 2 years, with Q1 2023 value amounting to $20.0 million.

  • Rigel Pharmaceuticals' Long-Term Debt Issuances rose 10000.0% to $20.0 million in Q1 2023 from the same period last year, while for Dec 2023 it was $20.0 million, marking a year-over-year increase of 208.78%. This contributed to the annual value of $20.0 million for FY2023, which is 208.78% up from last year.
  • Latest data reveals that Rigel Pharmaceuticals reported Long-Term Debt Issuances of $20.0 million as of Q1 2023, which was up 10000.0% from $9.6 million recorded in Q3 2022.
  • In the past 5 years, Rigel Pharmaceuticals' Long-Term Debt Issuances ranged from a high of $20.0 million in Q1 2023 and a low of -$33000.0 during Q2 2022